Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Asthma
Interventions
DRUG

IM epinephrine 1:1000

IM epinephrine 1:1000. The dose will be 0.2 mg for subjects 20-30 kg and 0.3 mg for subjects greater than 30 kg. This will be injected intramuscularly by an ED nurse into the anterior thigh muscles of the subject using a 1 ml syringe and a 23 gauge one inch needle.

OTHER

No intervention

A sham band-aid will be applied to the anterior thigh of subjects who are randomized to the no intervention group.

Trial Locations (1)

40202

Kosair Children's Hospital, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT01705964 - Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation | Biotech Hunter | Biotech Hunter